- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x KDH: (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate(Non-covalent)
- 46 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.2: 1 residues within 4Å:- Chain A: N.589
Ligand excluded by PLIPDMS.3: 5 residues within 4Å:- Chain A: W.61, I.62, Q.65, R.187
- Chain B: V.34
Ligand excluded by PLIPDMS.4: 3 residues within 4Å:- Chain A: H.195, W.209, R.345
Ligand excluded by PLIPDMS.5: 5 residues within 4Å:- Chain A: Q.213, V.215, A.266, I.269, K.288
Ligand excluded by PLIPDMS.6: 5 residues within 4Å:- Chain A: R.60, N.95, L.96, R.228, N.230
Ligand excluded by PLIPDMS.7: 4 residues within 4Å:- Chain A: Y.547, F.638, L.639, E.640
Ligand excluded by PLIPDMS.8: 5 residues within 4Å:- Chain A: E.699, E.700, F.702, F.703, R.780
Ligand excluded by PLIPDMS.9: 6 residues within 4Å:- Chain A: I.525, R.526, A.529, P.788, R.789, T.792
Ligand excluded by PLIPDMS.10: 5 residues within 4Å:- Chain A: R.513, E.695, E.696, A.697, G.698
Ligand excluded by PLIPDMS.11: 5 residues within 4Å:- Chain A: E.20, N.24, D.55, H.56
- Chain B: F.31
Ligand excluded by PLIPDMS.12: 2 residues within 4Å:- Chain A: R.27, H.30
Ligand excluded by PLIPDMS.13: 5 residues within 4Å:- Chain A: E.171
- Chain B: F.246, G.255, Y.256, A.259
Ligand excluded by PLIPDMS.14: 7 residues within 4Å:- Chain A: L.261, D.262, N.264, L.265
- Chain B: L.265, N.268
- Ligands: DMS.38
Ligand excluded by PLIPDMS.15: 2 residues within 4Å:- Chain A: G.414, D.415
Ligand excluded by PLIPDMS.16: 2 residues within 4Å:- Chain A: E.790, R.793
Ligand excluded by PLIPDMS.17: 4 residues within 4Å:- Chain A: T.191, L.216, N.244
- Ligands: DMS.23
Ligand excluded by PLIPDMS.18: 6 residues within 4Å:- Chain A: Y.274, K.283, L.285
- Chain B: I.257, Q.258, L.261
Ligand excluded by PLIPDMS.19: 4 residues within 4Å:- Chain A: Y.720, H.761, H.762, D.763
Ligand excluded by PLIPDMS.20: 2 residues within 4Å:- Chain A: F.280, E.281
Ligand excluded by PLIPDMS.21: 3 residues within 4Å:- Chain A: V.39, A.40, T.41
Ligand excluded by PLIPDMS.22: 5 residues within 4Å:- Chain A: R.10, Q.90, E.117, L.488
- Ligands: KDH.1
Ligand excluded by PLIPDMS.23: 8 residues within 4Å:- Chain A: P.188, T.191, L.216, K.241, N.244
- Chain B: R.178, Y.179
- Ligands: DMS.17
Ligand excluded by PLIPDMS.24: 7 residues within 4Å:- Chain A: R.421, T.460, I.461, F.462, K.463, D.464, F.465
Ligand excluded by PLIPDMS.26: 1 residues within 4Å:- Chain B: N.589
Ligand excluded by PLIPDMS.27: 5 residues within 4Å:- Chain A: V.34
- Chain B: W.61, I.62, Q.65, R.187
Ligand excluded by PLIPDMS.28: 3 residues within 4Å:- Chain B: H.195, W.209, R.345
Ligand excluded by PLIPDMS.29: 5 residues within 4Å:- Chain B: Q.213, V.215, A.266, I.269, K.288
Ligand excluded by PLIPDMS.30: 5 residues within 4Å:- Chain B: R.60, N.95, L.96, R.228, N.230
Ligand excluded by PLIPDMS.31: 4 residues within 4Å:- Chain B: Y.547, F.638, L.639, E.640
Ligand excluded by PLIPDMS.32: 5 residues within 4Å:- Chain B: E.699, E.700, F.702, F.703, R.780
Ligand excluded by PLIPDMS.33: 6 residues within 4Å:- Chain B: I.525, R.526, A.529, P.788, R.789, T.792
Ligand excluded by PLIPDMS.34: 5 residues within 4Å:- Chain B: R.513, E.695, E.696, A.697, G.698
Ligand excluded by PLIPDMS.35: 5 residues within 4Å:- Chain A: F.31
- Chain B: E.20, N.24, D.55, H.56
Ligand excluded by PLIPDMS.36: 2 residues within 4Å:- Chain B: R.27, H.30
Ligand excluded by PLIPDMS.37: 5 residues within 4Å:- Chain A: F.246, G.255, Y.256, A.259
- Chain B: E.171
Ligand excluded by PLIPDMS.38: 7 residues within 4Å:- Chain A: L.265, N.268
- Chain B: L.261, D.262, N.264, L.265
- Ligands: DMS.14
Ligand excluded by PLIPDMS.39: 2 residues within 4Å:- Chain B: G.414, D.415
Ligand excluded by PLIPDMS.40: 2 residues within 4Å:- Chain B: E.790, R.793
Ligand excluded by PLIPDMS.41: 4 residues within 4Å:- Chain B: T.191, L.216, N.244
- Ligands: DMS.47
Ligand excluded by PLIPDMS.42: 6 residues within 4Å:- Chain A: I.257, Q.258, L.261
- Chain B: Y.274, K.283, L.285
Ligand excluded by PLIPDMS.43: 4 residues within 4Å:- Chain B: Y.720, H.761, H.762, D.763
Ligand excluded by PLIPDMS.44: 2 residues within 4Å:- Chain B: F.280, E.281
Ligand excluded by PLIPDMS.45: 3 residues within 4Å:- Chain B: V.39, A.40, T.41
Ligand excluded by PLIPDMS.46: 5 residues within 4Å:- Chain B: R.10, Q.90, E.117, L.488
- Ligands: KDH.25
Ligand excluded by PLIPDMS.47: 8 residues within 4Å:- Chain A: R.178, Y.179
- Chain B: P.188, T.191, L.216, K.241, N.244
- Ligands: DMS.41
Ligand excluded by PLIPDMS.48: 7 residues within 4Å:- Chain B: R.421, T.460, I.461, F.462, K.463, D.464, F.465
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alexopoulos, S. et al., Evidence for the Quercetin Binding Site of Glycogen Phosphorylase as a Target for Liver-Isoform-Selective Inhibitors against Glioblastoma: Investigation of Flavanols Epigallocatechin Gallate and Epigallocatechin. J.Agric.Food Chem. (2024)
- Release Date
- 2024-10-30
- Peptides
- Glycogen phosphorylase, muscle form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.00 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x KDH: (2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate(Non-covalent)
- 46 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Alexopoulos, S. et al., Evidence for the Quercetin Binding Site of Glycogen Phosphorylase as a Target for Liver-Isoform-Selective Inhibitors against Glioblastoma: Investigation of Flavanols Epigallocatechin Gallate and Epigallocatechin. J.Agric.Food Chem. (2024)
- Release Date
- 2024-10-30
- Peptides
- Glycogen phosphorylase, muscle form: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A